CIK 0001878313
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAIA Biotechnology, Inc.
Sign in to watch- Ticker
- MAIA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 312-416-8592
- Business address
- 444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
- Open-market buys, last 90 days
- $352,317
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$352,317. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 36 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-31 | Guerrero Ramiro Director | Grant or award · Stock Options | +9,193 | 9,193 | ||
| 2024-03-31 | Luput Cristian Director | Grant or award · Stock Options | +9,193 | 9,193 | ||
| 2024-03-31 | Theagene Jean-Manasse Director | Grant or award · Stock Options | +9,193 | 9,193 | ||
| 2024-03-14 | CHAOUKI STEVEN M Director | Purchase | +34,641 | $1.17 | $41K | 88,891 |
| 2024-03-14 | CHAOUKI STEVEN M Director | Purchase · Warrants | +34,641 | $1.30 | $45K | 34,641 |
| 2024-03-14 | Smith Stan Director | Purchase | +170,940 | $1.17 | $200K | 857,568 |
| 2024-03-14 | Smith Stan Director | Purchase · Warrants | +170,940 | $1.30 | $222K | 170,940 |
| 2024-03-14 | Louie Ngar Yee Director | Purchase | +170,940 | $1.17 | $200K | 1,147,524 |
| 2024-03-14 | Louie Ngar Yee Director | Purchase · Warrants | +170,940 | $1.30 | $222K | 170,940 |
| 2024-03-14 | Luput Cristian Director | Purchase | +69,282 | $1.17 | $81K | 367,350 |
| 2024-03-14 | Luput Cristian Director | Purchase · Warrants | +69,282 | $1.30 | $90K | 69,282 |
| 2024-03-14 | Guerrero Ramiro Director | Purchase | +6,928 | $1.17 | $8K | 319,600.04 |
| 2024-03-14 | Guerrero Ramiro Director | Purchase · Warrants | +6,928 | $1.30 | $9K | 6,928 |
| 2024-01-24 | Gryaznov Sergei Chief Scientific Officer | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2024-01-24 | Vitoc Vlad Chief Executive Officer | Grant or award · Stock Options | +200,000 | 200,000 | ||
| 2024-01-24 | Himmelreich Jeffrey C Head of Finance | Grant or award · Stock Options | +10,000 | 10,000 | ||
| 2023-12-31 | Smith Stan Director | Grant or award · Stock Options | +19,273 | 19,273 | ||
| 2023-12-31 | Luput Cristian Director | Grant or award · Stock Options | +15,418 | 15,418 | ||
| 2023-12-31 | Louie Ngar Yee Director | Grant or award · Stock Options | +23,127 | 23,127 | ||
| 2023-12-31 | Guerrero Ramiro Director | Grant or award · Stock Options | +15,418 | 15,418 |
Page 9 of 14 · 270 trades